$LVO
LiveOne, Inc. Stock $lvo

$lvo Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924026422 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$32.59M	$33.08M	$27.77M
YoY Change	14.25%	19.13%	19.57%
Cost Of Revenue	$24.52M	$25.09M	$19.56M
YoY Change	19.33%	28.24%	27.18%
Gross Profit	$8.076M	$7.991M	$8.204M
YoY Change	1.19%	-2.6%	4.64%
Gross Profit Margin	24.78%	24.16%	29.55%
Selling, General & Admin	$7.774M	$6.936M	$6.967M
YoY Change	-9.66%	-0.44%	52.28%
% of Gross Profit	96.26%	86.8%	84.92%
Research & Development	$1.160M	$1.071M	$1.246M
YoY Change	-19.39%	-14.04%	-22.94%
% of Gross Profit	14.36%	13.4%	15.19%
Depreciation & Amortization	$800.0K	$1.412M	$800.0K
YoY Change	0.0%	76.5%	-11.11%
% of Gross Profit	9.91%	17.67%	9.75%
Operating Expenses	$8.934M	$8.007M	$8.213M
YoY Change	-11.05%	-2.51%	32.64%
Operating Profit	-$1.400M	-$784.0K	-$255.0K
YoY Change	-44.33%	207.45%	-207.59%
Interest Expense	-$808.0K	-$859.0K	-$1.418M
YoY Change	3.59%	-39.42%	42.23%
% of Operating Profit
Other Income/Expense, Net	-$926.0K	-$724.0K	-$181.0K
YoY Change	-82.96%	300.0%	-116.34%
Pretax Income	-$2.326M	-$1.508M	-$79.00K
YoY Change	-70.73%	1808.86%	-105.87%
Income Tax	-$9.000K	$49.00K	$436.0K
% Of Pretax Income
Net Earnings	-$1.859M	-$1.169M	-$515.0K
YoY Change	-75.47%	126.99%	-138.2%
Net Earnings / Revenue	-5.7%	-3.53%	-1.85%
Basic Earnings Per Share	-$0.02	-$0.02	-$0.01
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.01
COMMON SHARES
Basic Shares Outstanding	98.96M	98.96M	90.13M shares
Diluted Shares Outstanding			86.90M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.05M	$6.165M	$4.990M
YoY Change	206.52%	23.55%	-54.99%
Cash & Equivalents	$11.05M	$6.165M	$4.990M
Short-Term Investments
Other Short-Term Assets	$2.168M	$1.872M	$3.394M
YoY Change	-31.48%	-44.84%	74.23%
Inventory	$1.675M	$2.809M	$2.446M
Prepaid Expenses
Receivables	$14.08M	$14.76M	$16.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.98M	$25.61M	$26.83M
YoY Change	10.45%	-4.55%	-5.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.749M	$3.716M	$3.144M
YoY Change	25.38%	18.19%	-30.98%
Goodwill	$23.38M	$23.38M	$23.38M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$10.99M	$11.53M	$10.79M
YoY Change	-13.09%	6.86%	-29.59%
Long-Term Investments
YoY Change
Other Assets	$118.0K	$400.0K	$253.0K
YoY Change	-24.84%	58.1%	-61.37%
Total Long-Term Assets	$38.23M	$39.02M	$37.56M
YoY Change	-2.38%	3.88%	-14.45%
TOTAL ASSETS
Total Short-Term Assets	$28.98M	$25.61M	$26.83M
Total Long-Term Assets	$38.23M	$39.02M	$37.56M
Total Assets	$67.21M	$64.63M	$64.39M
YoY Change	2.76%	0.37%	-11.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.36M	$14.34M	$12.91M
YoY Change	60.02%	11.07%	-45.13%
Accrued Expenses	$12.21M	$12.71M	$12.77M
YoY Change	-11.99%	-0.42%	2.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$2.711M
YoY Change		-100.0%
Long-Term Debt Due	$7.690M	$7.691M	$7.014M
YoY Change	-0.05%	9.65%	53853.85%
Total Short-Term Liabilities	$51.27M	$48.15M	$50.86M
YoY Change	9.89%	-5.34%	-6.15%
LONG-TERM LIABILITIES
Long-Term Debt	$431.0K	$601.0K	$148.0K
YoY Change	-59.15%	306.08%	-99.45%
Other Long-Term Liabilities	$9.317M	$8.934M	$10.51M
YoY Change	4.61%	-15.02%	1747.63%
Total Long-Term Liabilities	$9.317M	$8.934M	$10.66M
YoY Change	4.61%	-16.2%	-61.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$51.27M	$48.15M	$50.86M
Total Long-Term Liabilities	$9.317M	$8.934M	$10.66M
Total Liabilities	$61.36M	$58.02M	$61.85M
YoY Change	7.5%	-6.2%	-24.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$248.6M	-$240.8M	-$225.4M
YoY Change	6.42%	6.85%	6.07%
Common Stock	$95.00K	$98.00K	$90.00K
YoY Change	4.4%	8.89%	8.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$250.0K	$5.531M	$3.175M
YoY Change	-93.33%	74.2%	218.46%
Treasury Stock Shares
Shareholders Equity	-$4.658M	-$3.809M	-$2.290M
YoY Change
Total Liabilities & Shareholders Equity	$67.21M	$64.63M	$64.39M
YoY Change	2.76%	0.37%	-11.03%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.859M	-$1.169M	-$515.0K
YoY Change	-75.47%	126.99%	-138.2%
Depreciation, Depletion And Amortization	$800.0K	$1.412M	$800.0K
YoY Change	0.0%	76.5%	-11.11%
Cash From Operating Activities	$5.772M	$1.300M	$1.221M
YoY Change	-556.28%	6.47%	-4796.15%
INVESTING ACTIVITIES
Capital Expenditures	$589.0K	$736.0K	$627.0K
YoY Change	-49.66%	17.38%	-18.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$589.0K	-$736.0K	-$627.0K
YoY Change	-49.66%	17.38%	-20.13%
FINANCING ACTIVITIES
Cash Dividend Paid		$509.0K	$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-420.0K	-$1.428M	-$4.013M
YoY Change	-141.3%	-64.42%	302.51%
NET CHANGE
Cash From Operating Activities	5.772M	$1.300M	$1.221M
Cash From Investing Activities	-589.0K	-$736.0K	-$627.0K
Cash From Financing Activities	-420.0K	-$1.428M	-$4.013M
Net Change In Cash	4.763M	-$822.0K	-$3.419M
YoY Change	-435.9%	-75.96%	89.1%
FREE CASH FLOW
Cash From Operating Activities	$5.772M	$1.300M	$1.221M
Capital Expenditures	$589.0K	$736.0K	$627.0K
Free Cash Flow	$5.183M	$564.0K	$594.0K
YoY Change	-312.85%	-5.05%	-174.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity File Number EntityFileNumber	001-38249
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0657263
CY2024Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	269 S. Beverly Dr., Suite #1450
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Beverly Hills
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90212
CY2024Q2	dei	City Area Code CityAreaCode	310
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	601-2505
CY2024Q2	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
CY2024Q2	dei	Trading Symbol TradingSymbol	LVO
CY2024Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98957316
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6165000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6987000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	155000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	155000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14760000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13205000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2809000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2187000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1717000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1801000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	25606000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	24335000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3716000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3646000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	23379000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	23379000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11528000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12415000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	400000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	88000	usd
CY2024Q2	us-gaap	Assets Assets	64629000	usd
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000
CY2024Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000
CY2024Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0
CY2024Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5000
CY2024Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	12797
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	12797
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	18814
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	18814
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94578077
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94578077
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88627420
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88627420
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	100000	usd
CY2022Q3	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrimeRateMember
CY2023Q3	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrimeRateMember
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P1Y
CY2020Q4	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000
CY2024Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	us-gaap	Assets Assets	63863000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	27050000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	26953000	usd
CY2024Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	12729000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	10862000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	691000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	692000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	675000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	728000	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000000	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	607000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	48145000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	46842000	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	601000	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	771000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8934000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9354000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	339000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	339000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	58019000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	57306000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	4962000	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	12797000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	18814000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	98000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	92000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	229674000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	216116000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	5531000	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	4782000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-240847000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-238984000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3809000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8744000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	10419000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	10339000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6610000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1595000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64629000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63863000	usd
CY2024Q2	us-gaap	Revenues Revenues	33078000	usd
CY2023Q2	us-gaap	Revenues Revenues	27767000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	25087000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	19563000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1431000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1904000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1071000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1246000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5505000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5063000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	176000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	592000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	246000	usd
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	33862000	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	28022000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-784000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-255000	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-859000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1418000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1237000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-724000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-181000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1508000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-436000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	79000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1557000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-515000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-388000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1169000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-515000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94419692
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86895208
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1595000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	782000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2024Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	4962000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1577000	usd
CY2024Q2	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance		usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	749000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1557000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6610000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1013000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	484000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	626000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	393000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1013000	usd
CY2023Q2	lvo	Net Income Loss Including Noncontrolling Interest NetIncomeLossIncludingNoncontrollingInterest	-515000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2290000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1557000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-515000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1412000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1055000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1616000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	877000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	986000	usd
CY2024Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	607000	usd
CY2023Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	826000	usd
CY2024Q2	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-50000	usd
CY2023Q2	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	176000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1505000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2339000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	255000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	285000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-84000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-150000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	312000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-124000	usd
CY2024Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-52000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-23000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	904000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1715000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1350000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	302000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	138000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1342000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1221000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	736000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	627000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-736000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-627000	usd
CY2024Q2	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	-0	usd
CY2023Q2	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	3000000	usd
CY2024Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	509000	usd
CY2023Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	-0	usd
CY2024Q2	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-170000	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	749000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1013000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1428000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4013000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-822000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3419000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7142000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8649000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6320000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5230000	usd
CY2024Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	196000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	125000	usd
CY2024Q2	us-gaap	Stock Issued1 StockIssued1	366000	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2024Q2	lvo	Fair Value Of Accrued Shares FairValueOfAccruedShares	220000	usd
CY2023Q2	lvo	Fair Value Of Accrued Shares FairValueOfAccruedShares	0	usd
CY2024Q2	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	118000	usd
CY2023Q2	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	usd
CY2024Q2	lvo	Fair Value Of Options To Employees Capitalized As Software FairValueOfOptionsToEmployeesCapitalizedAsSoftware	155000	usd
CY2023Q2	lvo	Fair Value Of Options To Employees Capitalized As Software FairValueOfOptionsToEmployeesCapitalizedAsSoftware	3000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6300000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1600000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1300000	usd
CY2024Q2	lvo	Working Capital WorkingCapital	-22500000	usd
CY2024Q2	lvo	Potential Financing Amount PotentialFinancingAmount	150000000	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of the Company’s condensed consolidated financial statements in conformity with the United States of America (“US”) generally accepted accounting principles (“GAAP”) requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, inventory calculations and reserves, the fair value of the Company’s equity-based compensation awards and convertible debt and debenture instruments, fair values of derivatives, and contingencies. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. There is a reasonable possibility that actual results could differ from those estimates and such differences could be material to the financial position and results of operations, specifically in assessing when the collectability of revenue related consideration is probable, and the impairment assessment of goodwill, indefinite lived assets or long-lived assets that are depreciated or amortized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	100000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2266667
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3500191
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1169000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-515000	usd
CY2024Q2	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	378000	usd
CY2023Q2	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	-0	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	316000	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1863000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-515000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94419692
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86895208
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6165000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6987000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	155000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	155000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6320000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7142000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	15765000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	14260000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1005000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1055000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	14760000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	13205000	usd
CY2024Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Concentration of Credit Risk</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the <em style="font: inherit;">$250,000</em> amount insured by the Federal Deposit Insurance Corporation. The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk with respect to such cash and cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33078000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27767000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	728000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	303000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	250000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	675000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23476000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25826000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19760000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22180000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3716000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3646000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	800000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	800000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	23379000	usd
CY2024Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	-0	usd
CY2024Q2	us-gaap	Goodwill Goodwill	23379000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	39271000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-32380000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6891000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	39566000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-31788000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7778000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	200000	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1536000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1762000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1023000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	508000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	508000	usd
CY2024Q2	lvo	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	1554000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6891000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	14338000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	15154000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12712000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11708000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	91000	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	27050000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	26953000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	1292000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	1463000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	691000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	692000	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	601000	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	771000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	155000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	159000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	67000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	48000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	222000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	207000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	88000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	91000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	91000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.085	pure
CY2024Q2	lvo	Accrued Royalties Noncurrent AccruedRoyaltiesNoncurrent	6991000	usd
CY2024Q1	lvo	Accrued Royalties Noncurrent AccruedRoyaltiesNoncurrent	7508000	usd
CY2024Q2	lvo	Sales And Excise Tax Payable Noncurrent SalesAndExciseTaxPayableNoncurrent	1842000	usd
CY2024Q1	lvo	Sales And Excise Tax Payable Noncurrent SalesAndExciseTaxPayableNoncurrent	1706000	usd
CY2024Q2	lvo	Other Liabilities Noncurrent Miscellaneous OtherLiabilitiesNoncurrentMiscellaneous	101000	usd
CY2024Q1	lvo	Other Liabilities Noncurrent Miscellaneous OtherLiabilitiesNoncurrentMiscellaneous	140000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8934000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9354000	usd
CY2024Q2	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.05	pure
CY2024Q2	lvo	Stock Authorized StockAuthorized	510000000
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	lvo	Stock Repurchase Program Increase In Authorized Amount StockRepurchaseProgramIncreaseInAuthorizedAmount	2000000	usd
CY2024Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	402593
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	694315
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	700000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1000000	usd
CY2023Q3	lvo	Stock Issued To Noncontrolling Owners StockIssuedToNoncontrollingOwners	4300000
CY2023Q3	lvo	Stock Issued To Noncontrolling Owners StockIssuedToNoncontrollingOwners	4300000
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1500000	usd
	lvo	Stock Issued To Noncontrolling Owners StockIssuedToNoncontrollingOwners	3200000
CY2024	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	2500000	usd
CY2024Q2	us-gaap	Revenues Revenues	33078000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1557000	usd
CY2023Q2	us-gaap	Revenues Revenues	27767000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-515000	usd

Files In Submission

Name	View Source	Status
0001437749-24-026422-index-headers.html	Edgar Link	pending
0001437749-24-026422-index.html	Edgar Link	pending
0001437749-24-026422.txt	Edgar Link	pending
0001437749-24-026422-xbrl.zip	Edgar Link	pending
ex_697354.htm	Edgar Link	pending
ex_697355.htm	Edgar Link	pending
ex_697356.htm	Edgar Link	pending
ex_697357.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lvo-20240630.xsd	Edgar Link	pending
lvo20240630c_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
lvo-20240630_cal.xml	Edgar Link	unprocessable
lvo-20240630_def.xml	Edgar Link	unprocessable
lvo-20240630_lab.xml	Edgar Link	unprocessable
lvo-20240630_pre.xml	Edgar Link	unprocessable
lvo20240630c_10q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LVO
LiveOne, Inc. Stock $lvo

2024 Q3 Form 10-Q Financial Statement

#000143774924026422 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LVO LiveOne, Inc. Stock $lvo

2024 Q3 Form 10-Q Financial Statement

#000143774924026422 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LVO
LiveOne, Inc. Stock $lvo